Alpha 2.0
Login Register
» Articles » PMID: 29116987

A Substance Use Cost Calculator for US Employers With an Emphasis on Prescription Pain Medication Misuse

Overview
Journal J Occup Environ Med
Specialty Environmental Health
Date 2017 Nov 9
PMID 29116987
Citations 16
Authors
Eric Goplerud
Sarah Hodge
Tess Benham
Affiliations
Soon will be listed here.
Abstract

Objective: Substance use disorders are among the most common and costly health conditions affecting Americans. Despite estimates of national costs exceeding $400 billion annually, individual companies may not see how substance use impacts their bottom lines through lost productivity and absenteeism, turnover, health care expenses, disability, and workers' compensation.

Methods: Data on employed adults (18 years and older) from 3 years (2012 to 2014) of the National Survey on Drug Use and Health Public Use Data Files were analyzed.

Results: The results offer employers an authoritative, free, epidemiologically grounded, and easy-to-use tool that gives specific information about how alcohol, prescription pain medication misuse, and illicit drug use is likely impacting workplaces like theirs.

Conclusion: Employers have detailed reports of the cost of substance use that can be used to improve workplace policies and health benefits.

Citing Articles

Exploring the Perceptions of Construction Workers and Senior Management Towards Mental Wellness Interventions Using Q-Methodology.

Stoddard E, Bhandari S, Sherratt F, Bone L, Russell S Int J Environ Res Public Health. 2025; 22(1).

PMID: 39857504 PMC: 11765110. DOI: 10.3390/ijerph22010052.

Artificial Intelligence and Occupational Health and Safety, Benefits and Drawbacks.

El-Helaly M Med Lav. 2024; 115(2):e2024014.

PMID: 38686574 PMC: 11181216. DOI: 10.23749/mdl.v115i2.15835.

The Functional-Cognitive and Sensory Treatment (F-CaST) to improve rehabilitation outcomes of individuals with substance use disorder: a study protocol for a mixed-method randomized controlled trial.

Assayag N, Bar-Shalita T, Rand D Addict Sci Clin Pract. 2024; 19(1):28.

PMID: 38594737 PMC: 11003090. DOI: 10.1186/s13722-024-00449-7.

Active learning impairments in substance use disorders when resolving the explore-exploit dilemma: A replication and extension of previous computational modeling results.

Taylor S, Lavalley C, Hakimi N, Stewart J, Ironside M, Zheng H Drug Alcohol Depend. 2023; 252:110945.

PMID: 37717307 PMC: 10635739. DOI: 10.1016/j.drugalcdep.2023.110945.

Workplace Supported Recovery from Substance Use Disorders: Defining the Construct, Developing a Model, and Proposing an Agenda for Future Research.

Frone M, Chosewood L, Osborne J, Howard J Occup Health Sci. 2023; 6(4):475-511.

PMID: 37206918 PMC: 10193449. DOI: 10.1007/s41542-022-00123-x.

References
1.
Harrison L . The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res Monogr. 1997; 167:17-36. View
2.
Richmond M, Pampel F, Wood R, Nunes A . Impact of Employee Assistance Services on Depression, Anxiety, and Risky Alcohol Use: A Quasi-Experimental Study. J Occup Environ Med. 2016; 58(7):641-50. DOI: 10.1097/JOM.0000000000000744. View
3.
Rudd R, Aleshire N, Zibbell J, Gladden R . Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016; 64(50-51):1378-82. DOI: 10.15585/mmwr.mm6450a3. View
4.
Greenfield T, Nayak M, Bond J, Kerr W, Ye Y . Test-retest reliability and validity of life-course alcohol consumption measures: the 2005 National Alcohol Survey follow-up. Alcohol Clin Exp Res. 2014; 38(9):2479-87. PMC: 4177326. DOI: 10.1111/acer.12480. View
5.
Harrell A . The validity of self-reported drug use data: the accuracy of responses on confidential self-administered answered sheets. NIDA Res Monogr. 1997; 167:37-58. View